T. KORKMAZ Et Al. , "Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)," 47th American Society of Clinical Oncology (ASCO) Annual Meeting , 2011
KORKMAZ, T. Et Al. 2011. Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC). 47th American Society of Clinical Oncology (ASCO) Annual Meeting .
KORKMAZ, T., ŞEBER, E. S., BAŞARAN, G., YUMUK, P. F., DANE, F., OKUTUR, S. K., ... Kanıtez, M.(2011). Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC) . 47th American Society of Clinical Oncology (ASCO) Annual Meeting
KORKMAZ, TANER Et Al. "Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)," 47th American Society of Clinical Oncology (ASCO) Annual Meeting, 2011
KORKMAZ, TANER Et Al. "Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)." 47th American Society of Clinical Oncology (ASCO) Annual Meeting , 2011
KORKMAZ, T. Et Al. (2011) . "Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)." 47th American Society of Clinical Oncology (ASCO) Annual Meeting .
@conferencepaper{conferencepaper, author={TANER KORKMAZ Et Al. }, title={Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)}, congress name={47th American Society of Clinical Oncology (ASCO) Annual Meeting}, city={}, country={}, year={2011}}